Abstract
Background: A systematic review suggests that 25% of oesophageal adenocarcinomas (OAC) are 'missed' at index endoscopy for Barrett's oesophagus (BO); however, this included few population-based studies and may be an overestimate.
Objective: The objective of this article is to quantify the 'missed' rates of high-grade dysplasia (HGD) and OAC at index BO endoscopy.
Methods: Patients from the Northern Ireland BO register diagnosed between 1993 and 2010 (n = 13,159) were linked to the Northern Ireland Cancer Registry to identify patients who developed OAC or HGD. Logistic regression analysis compared characteristics of 'missed' vs 'incident' HGD/OAC, defined as diagnoses within 3-12 months vs >1 year after incident BO, respectively.
Results: A total of 267 patients were diagnosed with HGD/OAC ≥3 months after BO diagnosis, of whom 34 (12.7%) were potentially 'missed'. The proportion of 'missed' HGD/OAC was 25% among BO patients with low-grade dysplasia (LGD) and 9% among non-dysplastic BO patients. Older age and BO-LGD carried a higher risk of 'missed' HGD/OAC. Non-dysplastic BO patients were more often diagnosed with a 'missed' OAC (rather than HGD; 89%), compared with BO-LGD patients (40%).
Conclusions: Approximately one in 10 HGD/OAC cases are 'missed' at incident BO diagnosis, which is significant but lower than previous reports. However, 'missed' HGD/OAC cases represent only 0.26% of all BO patients.
| Original language | English |
|---|---|
| Pages (from-to) | 519-528 |
| Number of pages | 10 |
| Journal | United European Gastroenterology Journal |
| Volume | 6 |
| Issue number | 4 |
| Early online date | 11 Oct 2017 |
| DOIs | |
| Publication status | Published - 01 May 2018 |
Access to Document
- Manuscript_missed_esophageal_adenocarcinoma_in_Barrett_pte_R1_HC_accepted
Copyright 2017 Sage This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.